Atlas Trials

Relapse or Refractory Myeloid Malignancies

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapse or Refractory Myeloid Malignancies

RecordFirmDate
A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma. (NCT07779798)Crossbow Therapeutics, Inc.2026-08-01

Track Relapse or Refractory Myeloid Malignancies automatically

Every clearance here is in the API, with alerts when new ones post.